Search results
Found 560 matches for
PepGen has been awarded a grant of £1.6 M from Innovate UK, the UK’s innovation agency. The company’s project, entitled ‘Application of a novel peptide delivery platform to nucleic acid therapeutics in degenerative and rare diseases’, will run for 20 months, and this funding will be instrumental in supporting the pre-clinical development of PepGen’s innovative technology.
